HOOKIPA Pharma Inc. (NASDAQ:HOOK – Get Free Report) shares were up 0.9% during mid-day trading on Tuesday . The stock traded as high as $0.8877 and last traded at $0.8877. Approximately 2,823 shares were traded during trading, a decline of 97% from the average daily volume of 90,478 shares. The stock had previously closed at $0.88.
HOOKIPA Pharma Stock Up 0.9%
The firm has a fifty day moving average of $0.88 and a 200-day moving average of $0.97. The firm has a market cap of $10.82 million, a P/E ratio of -0.15 and a beta of 0.91.
HOOKIPA Pharma Company Profile
HOOKIPA Pharma Inc is a clinical-stage biotechnology company focused on the development of virus-based immunotherapies and vaccines. The company operates two complementary platform technologies—an engineered Modified Vaccinia Ankara (MVA) vector and an arenavirus vector system—designed to stimulate both humoral and cellular immune responses. By combining these platforms, HOOKIPA aims to address infectious diseases and drive novel immuno-oncology treatments.
In the infectious disease arena, HOOKIPA’s pipeline includes prophylactic vaccine candidates targeting pathogens such as cytomegalovirus (CMV) in transplant settings and other viral threats.
Read More
- Five stocks we like better than HOOKIPA Pharma
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for HOOKIPA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HOOKIPA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
